Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Supplements That Help With Hypoglycemia on Ozempic: What the Evidence Actually Shows

By
Published Updated Last reviewed
3 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Ozempic alone, documented symptomatic hypoglycemia at 70 mg/dL or below / 0% on placebo, 1.6% on 0.5 mg, 3.8% on 1 mg [1]
  • Ozempic added to basal insulin, same measure / 15.2% on placebo, 16.7% on 0.5 mg, 29.8% on 1 mg [1]
  • Label on the companion drug / reducing the sulfonylurea or insulin dose may lower the risk [1]
  • Alpha-lipoic acid, 24 pooled trials / fasting glucose SMD -0.54; HbA1c SMD -1.22 [2]
  • Magnesium in type 2 diabetes / deficits are common, especially with poor glycemic control [3]

Does Ozempic cause hypoglycemia on its own?

In a 30-week monotherapy trial (129 on placebo, 127 on 0.5 mg, 130 on 1 mg), documented symptomatic hypoglycemia at 70 mg/dL or below occurred in 0%, 1.6% and 3.8%, and no severe episodes were reported in any arm [1].

Adding basal insulin changes the numbers. In a 30-week trial of Ozempic added to basal insulin with or without metformin (132, 132 and 131 patients), the same measure was 15.2% on placebo, 16.7% on 0.5 mg and 29.8% on 1 mg, and severe or blood-glucose-confirmed events at 56 mg/dL or below were 5.3%, 8.3% and 10.7% [1]. The Ozempic label reports more frequent hypoglycemia when Ozempic was used with a sulfonylurea [1].

What the label says about the companion drug

Section 5.5 states that patients receiving Ozempic with an insulin secretagogue such as a sulfonylurea, or with insulin, may have an increased risk of hypoglycemia including severe hypoglycemia, and that the risk may be lowered by a reduction in the dose of the sulfonylurea or insulin [1]. Section 7.1 says that when Ozempic is initiated, consider reducing the dose of the insulin secretagogue or insulin [1]. Severe episodes are defined in the label as those requiring the assistance of another person [1].

What the supplement research measured

Alpha-lipoic acid. A 2018 meta-analysis pooled 24 randomized trials in people with metabolic diseases; supplementation lowered fasting glucose (standardized mean difference -0.54; 95% CI -0.89 to -0.19) and HbA1c (SMD -1.22; 95% CI -2.01 to -0.44) compared with control [2]. Standardized mean differences pool results reported in different units; they are not a mg/dL figure.

Magnesium. A review of magnesium and type 2 diabetes reports that magnesium deficits are frequent in type 2 diabetes, especially with poorly controlled glucose, and that benefits of supplementation on metabolic profiles were found in most but not all clinical studies, with larger prospective studies needed [3].

Frequently asked questions

Can Ozempic cause low blood sugar without insulin or a sulfonylurea?
In a 30-week monotherapy trial, documented symptomatic hypoglycemia at 70 mg/dL or below occurred in 1.6% on 0.5 mg and 3.8% on 1 mg versus 0% on placebo, and no severe episodes were reported in any arm [1].
What glucose thresholds do the Ozempic trials use?
The label tables report documented symptomatic hypoglycemia at 70 mg/dL or below, and a second category of severe or blood-glucose-confirmed symptomatic events at 56 mg/dL or below; severe episodes are defined as those requiring the assistance of another person [1].
Does magnesium improve blood sugar control in type 2 diabetes?
The magnesium review says deficits are common in type 2 diabetes and that benefits of supplementation on metabolic profiles were found in most but not all clinical studies, with larger prospective studies still needed [3].
What did the alpha-lipoic acid meta-analysis find?
Across 24 randomized trials in people with metabolic diseases, alpha-lipoic acid lowered fasting glucose (SMD -0.54) and HbA1c (SMD -1.22) compared with control [2]. These are glucose-control outcomes, not hypoglycemia outcomes.

References

  1. U.S. National Library of Medicine, DailyMed. Ozempic injection (Novo Nordisk) prescribing information. Ozempic injection (Novo Nordisk) label
  2. Akbari M, Ostadmohammadi V, Lankarani KB, Tabrizi R, Kolahdooz F, Khatibi SR, et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Metabolism. 2018;87:56-69. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
  3. Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World J Diabetes. 2015;6(10):1152-7. Magnesium and type 2 diabetes
Evidence overview for Supplements That Help With Hypoglycemia on Ozempic: What the Evidence Actually Shows